Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ran Reshef

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
International Journal of Hematologic Oncology|October 11, 2018
Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNSSarah J Nagle, Nirav N Shah, Alex Ganetsky, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
A Conserved Landscape of Chemokine Receptor Co-expression Defines the Functional States of CD8+ T Cells in MelanomaRodney Macedo, David W Harle, Kevin Hoffer-Hawlik, et al.
Blood|March 20, 2015
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTMobin A Karimi, Jerrod L Bryson, Lee P Richman, et al.
JACC. Cardiooncology|January 13, 2023
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLDDaniel Oren, Ersilia M DeFilippis, Dor Lotan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2013
Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patientsMeghan Karuturi, Nirav Shah, Dale Frank, et al.
American Journal of Hematology|May 21, 2016
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantationClinton Yam, Lisa Crisalli, Selina M Luger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2009
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantationGregory L Beatty, Jasmine S Smith, Ran Reshef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository StudyRan Reshef, Wael Saber, Javier Bolaños-Meade, et al.
American Journal of Hematology|January 29, 2016
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLIAnita J Kumar, Pavel Vassilev, Alison W Loren, et al.
Transplantation and Cellular Therapy|December 27, 2022
Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 StudySantosh Putta, Bradford A Young, John E Levine, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
International Journal of Hematologic Oncology|October 11, 2018
Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNSSarah J Nagle, Nirav N Shah, Alex Ganetsky, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
A Conserved Landscape of Chemokine Receptor Co-expression Defines the Functional States of CD8+ T Cells in MelanomaRodney Macedo, David W Harle, Kevin Hoffer-Hawlik, et al.
Blood|March 20, 2015
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTMobin A Karimi, Jerrod L Bryson, Lee P Richman, et al.
JACC. Cardiooncology|January 13, 2023
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLDDaniel Oren, Ersilia M DeFilippis, Dor Lotan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2013
Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patientsMeghan Karuturi, Nirav Shah, Dale Frank, et al.
American Journal of Hematology|May 21, 2016
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantationClinton Yam, Lisa Crisalli, Selina M Luger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2009
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantationGregory L Beatty, Jasmine S Smith, Ran Reshef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository StudyRan Reshef, Wael Saber, Javier Bolaños-Meade, et al.
American Journal of Hematology|January 29, 2016
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLIAnita J Kumar, Pavel Vassilev, Alison W Loren, et al.
Transplantation and Cellular Therapy|December 27, 2022
Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 StudySantosh Putta, Bradford A Young, John E Levine, et al.
Pageof 15